ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................JBDM Ver 0.1.67 (18 Oct 2017) - 2999001/03228322CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120190619W173deBibliographieenBibliographyfrBibliographieEP15865520.92015120120170703jaenen201424442120141202JP2019061920192520171011201741201904102019152018121820190619201925A61K 31/7125 20060101AFI20181114BHEP C12N 15/117 20100101ALI20181114BHEP A61K 39/00 20060101ALI20181114BHEP A61K 39/39 20060101ALI20181114BHEP C12N 15/09 20060101ALI20181114BHEP deHILFSSTOFFZUSAMMENSETZUNGenADJUVANT COMPOSITIONfrCOMPOSITION D'ADJUVANTWO-A1-2008/065752WO-A1-2012/014945ZUNIGA ET AL: "Attenuated measles virus as a vaccine vector", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 16, 29 March 2007 (2007-03-29), pages 2974-2983, XP022004277, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2007.01.06420180504SEYA, Tsukasac/o NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY Kita 8-jyo Nishi 5-chome Kita-kuSapporo-shi Hokkaido 060-0808JPMATSUMOTO, Misakoc/o NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY Kita 8-jyo Nishi 5-chome Kita-kuSapporo-shi Hokkaido 060-0808JPAdvanced Innovation Development Co. Ltd.10181491057291-10-2, Kanda-OgawamachiChiyoda-ku Tokyo, 101-0052JPKnoop, Philipp101092025VKK Patentanwälte PartG mbB An der Alster 8420099 HamburgDEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRJP201508382520151201jaWO201608878420160609201623